{"id":"https://openalex.org/W7225289482","doi":null,"title":"Formulation and in vitro comparative evaluation of orodispersible tablets of granisetron hydrochloride","display_name":"Formulation and in vitro comparative evaluation of orodispersible tablets of granisetron hydrochloride","publication_year":2012,"publication_date":"2012-03-01","ids":{"openalex":"https://openalex.org/W7225289482"},"language":"en","primary_location":{"id":"pmh:oai:doaj.org/article:0ba7d65e7ac046fdb675b1483d8e31af","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/0ba7d65e7ac046fdb675b1483d8e31af","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Research in Pharmaceutical Sciences, Vol 3, Iss 2, Pp 195-199 (2012)","raw_type":"article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160619002","display_name":"Srinivasa DS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Srinivasa DS","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043785530","display_name":"Narayana Rompicherla Charyulu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Narayana Charyulu R","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110070995","display_name":"Prabhakara Prabhu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prabhakara Prabhu*","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160598497","display_name":"Nithish Kumar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nithish Kumar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036478365","display_name":"Marina Koland","orcid":"https://orcid.org/0000-0003-2628-3582","observed_orcids":["https://orcid.org/0000-0003-2628-3582"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina Koland","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160705452","display_name":"Srilakshmi D","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Srilakshmi D","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5160606636","display_name":"Satyanarayana DS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Satyanarayana DS","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.453283,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9535999894142151,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9535999894142151,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.029899999499320984,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/granisetron-hydrochloride","display_name":"granisetron hydrochloride","score":0.9950000047683716},{"id":"https://openalex.org/keywords/orally-disintegrating-tablets","display_name":"orally disintegrating tablets","score":0.984000027179718},{"id":"https://openalex.org/keywords/superdisintegrants","display_name":"superdisintegrants","score":0.949999988079071},{"id":"https://openalex.org/keywords/sublimation-method","display_name":"sublimation method","score":0.7490000128746033},{"id":"https://openalex.org/keywords/in-vitro-disintegration","display_name":"in vitro disintegration","score":0.8550000190734863},{"id":"https://openalex.org/keywords/drug-release-kinetics","display_name":"drug release kinetics","score":0.9229999780654907},{"id":"https://openalex.org/keywords/tablet-stability","display_name":"tablet stability","score":0.9129999876022339},{"id":"https://openalex.org/keywords/pediatric-drug-formulation","display_name":"pediatric formulations","score":0.6290000081062317},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.9679999947547913}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5817000269889832},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5303999781608582},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.5060999989509583},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4968000054359436},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4821999967098236},{"id":"https://openalex.org/C2777452722","wikidata":"https://www.wikidata.org/wiki/Q596708","display_name":"Granisetron","level":4,"score":0.45339998602867126},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4397999942302704},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.397599995136261},{"id":"https://openalex.org/C2986629439","wikidata":"https://www.wikidata.org/wiki/Q9635","display_name":"Oral cavity","level":2,"score":0.27300000190734863},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.2581999897956848},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.25209999084472656}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:doaj.org/article:0ba7d65e7ac046fdb675b1483d8e31af","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/0ba7d65e7ac046fdb675b1483d8e31af","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Research in Pharmaceutical Sciences, Vol 3, Iss 2, Pp 195-199 (2012)","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2424825057","https://openalex.org/W2345538851","https://openalex.org/W2184079631","https://openalex.org/W2186423631","https://openalex.org/W4365601391","https://openalex.org/W2358029729","https://openalex.org/W2187413270","https://openalex.org/W3209381741","https://openalex.org/W7166167045","https://openalex.org/W7096950288"],"abstract_inverted_index":{"In":[0],"the":[1,27,69,88],"present":[2],"work,":[3],"an":[4],"attempt":[5],"has":[6],"been":[7],"made":[8],"to":[9,101],"formulate":[10],"oral":[11,113],"dispersible":[12,114],"tablets":[13,34,115],"of":[14,29,33,90,116],"granisetron":[15,117],"HCl":[16,118],"by":[17,63,104],"three":[18],"different":[19],"methods.":[20,108],"Conventional":[21],"tabletting":[22],"procedure":[23],"was":[24,110],"followed":[25],"for":[26,39,133],"preparation":[28],"tablets.":[30],"Nine":[31],"batches":[32],"were":[35],"prepared":[36,62,103],"and":[37,42,58,84,96,106,123,135],"evaluated":[38],"general":[40],"appearance":[41],"physical":[43],"parameters,":[44],"drug":[45,55,85,130],"content,":[46],"in":[47,50,53,76,80],"vitro":[48,51,54,77,81],"disintegration,":[49],"dispersion,":[52],"release,":[56],"kinetic":[57],"stability":[59],"studies.":[60],"Formulations":[61],"superdisintegrants":[64],"addition":[65],"method":[66],"emerged":[67],"as":[68,72,127],"best":[70],"formulations,":[71],"they":[73],"showed":[74],"rapid":[75],"disintegration":[78],"time,":[79],"dispersion":[82],"time":[83],"release":[86],"at":[87],"end":[89],"5":[91],"min,":[92],"apart":[93],"from":[94],"taste":[95],"excellent":[97],"mouth":[98],"feel":[99],"compared":[100],"formulations":[102],"sublimation":[105],"effervescent":[107],"It":[109],"concluded":[111],"that":[112],"can":[119],"be":[120,125],"successfully":[121],"formulated":[122],"will":[124],"used":[126],"a":[128],"novel":[129],"dosage":[131],"form":[132],"pediatrics":[134],"geriatrics":[136],"with":[137],"improved":[138],"patient":[139],"compliance.":[140]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-11-05T00:00:00"}